Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Functional characterization of the biogenic amine transporters on human macrophages
Phillip M. Mackie, Adithya Gopinath, Dominic M. Montas, Alyssa Nielsen, Aidan Smith, Rachel A. Nolan, Kaitlyn Runner, Stephanie M. Matt, John McNamee, Joshua E. Riklan, Kengo Adachi, Andria Doty, Adolfo Ramirez-Zamora, Long Yan, Peter J. Gaskill, Wolfgang J. Streit, Michael S. Okun, Habibeh Khoshbouei
Phillip M. Mackie, Adithya Gopinath, Dominic M. Montas, Alyssa Nielsen, Aidan Smith, Rachel A. Nolan, Kaitlyn Runner, Stephanie M. Matt, John McNamee, Joshua E. Riklan, Kengo Adachi, Andria Doty, Adolfo Ramirez-Zamora, Long Yan, Peter J. Gaskill, Wolfgang J. Streit, Michael S. Okun, Habibeh Khoshbouei
View: Text | PDF
Research Article Inflammation Neuroscience

Functional characterization of the biogenic amine transporters on human macrophages

  • Text
  • PDF
Abstract

Monocyte-derived macrophages (MDMs) are key players in tissue homeostasis and diseases regulated by a variety of signaling molecules. Recent literature has highlighted the ability for biogenic amines to regulate macrophage functions, but the mechanisms governing biogenic amine signaling in and around immune cells remain nebulous. In the CNS, biogenic amine transporters are regarded as the master regulators of neurotransmitter signaling. While we and others have shown that macrophages express these transporters, relatively little is known of their function in these cells. To address these knowledge gaps, we investigated the function of norepinephrine transporter (NET) and dopamine transporter (DAT) on human MDMs. We found that both NET and DAT are present and can uptake substrate from the extracellular space at baseline. Not only was DAT expressed in cultured MDMs, but it was also detected in a subset of intestinal macrophages in situ. Surprisingly, we discovered a NET-independent, DAT-mediated immunomodulatory mechanism in response to LPS. LPS induced reverse transport of dopamine through DAT, engaging an autocrine/paracrine signaling loop that regulated the macrophage response. Removing this signaling loop enhanced the proinflammatory response to LPS. Our data introduce a potential role for DAT in the regulation of innate immunity.

Authors

Phillip M. Mackie, Adithya Gopinath, Dominic M. Montas, Alyssa Nielsen, Aidan Smith, Rachel A. Nolan, Kaitlyn Runner, Stephanie M. Matt, John McNamee, Joshua E. Riklan, Kengo Adachi, Andria Doty, Adolfo Ramirez-Zamora, Long Yan, Peter J. Gaskill, Wolfgang J. Streit, Michael S. Okun, Habibeh Khoshbouei

×

Figure 6

LPS stimulation decreases DAT-mediated uptake without affecting membrane or total DAT levels.

Options: View larger image (or click on image) Download as PowerPoint
LPS stimulation decreases DAT-mediated uptake without affecting membrane...
(A) Representative 40× images of unstimulated or LPS-stimulated macrophages assayed for DAT-mediated IDT307 uptake. (B) DAT-mediated uptake, measured as fold increase in fluorescence intensity, was calculated as described in Figure 3F. Compared with unstimulated macrophages (control group), LPS stimulation decreased the DAT-mediated IDT307 uptake. (C–E) LPS-stimulation decreased the magnitude (C, AUC, P = 0.03, Mann Whitney U test), max fluorescence (D, P = 0.07, Mann Whitney U test), and the rate (E, average slope, P = 0.01, Mann Whitney U test) of DAT-dependent IDT307 uptake. Data are from n = 9 independent experiments/group. (F) Representative whole-cell current traces from unstimulated or LPS-stimulated macrophages. (G and H) The current–voltage curves show the DAT-mediated inward currents at different hyperpolarizing voltage steps for unstimulated (G) and LPS-stimulated (H) macrophages. DAT-mediated inward currents were calculated by subtracting the inward current in the presence of nomifensine from the inward currents at baseline or in the presence amphetamine (AMPH). (I) In unstimulated macrophages, amphetamine induced a nomifensine-sensitive inward current (P = 0.02); however, LPS stimulation decreased the amphetamine-induced DAT-mediated current (P = 0.01). Data in F–I are from 4–7 experiments/group, and statistical analysis was performed via 2-way ANOVA with Tukey’s post hoc test for multiple comparisons. (J) Representative immunoblot of membrane and cytoplasmic DAT in macrophages measured by surface biotinylation in the presence or absence of LPS. YFP-DAT-expressing CHO cells and parental CHO cells were used as positive and negative controls, respectively. Cytosolic and membrane fractions confirmed by HSP60 (lower panel). (K and L) Surface DAT (K) and total DAT levels (L) are expressed as percentage HSP60 ± SEM, n = 4 independent biological replicates. LPS did not alter membrane DAT levels (P = 0.9, unpaired 2-tailed t test).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts